Abbiyesuku F M, Shittu O B, Oduwole O O, Osotimehin B O
Department of Chemical Pathology, University College Hospital, Ibadan, Ibadan, Nigeria.
Afr J Med Med Sci. 2000 Jun;29(2):97-100.
The biological characteristics of prostate-specific antigen were studied in the Nigerian African. Two hundred and fourteen persons were selected for the study. The group was made up of 59 apparently healthy men (age range 22-76 years), 58 men (age range 40-91 years) who had biopsy proven diagnosis of cancer of the prostate gland, 81 men (age range 46-87 years) who had biopsy proven benign prostatic hypertrophy (BPH) and 16 women (age range 23-47 years). Their median ages were 53 years, 66 years, 66 years and 27 years, respectively. The median PSA value among the control population was 0.7 ug/L (range 0.1-4.3 ug/L) and 98.3% of them had PSA of less than 4 ug/L. No person below 50 years of age had PSA value greater than 2 ug/L. There was a significant correlation between age and serum PSA value over the entire age range (r = 0.523; P = 0.001). In the female study group, 4(25%) had detectable values the cause of which could not be determined. The median PSA value among the BPH patients was 8.5 ug/L (range 0.2-350 ug/L). In this group 37% of them had values below 4 ug/L and 54.3% of them had values less than 10 ug/L. Among the patients who had cancer of the prostate gland the median PSA value was 92.6 ug/L and the mode was greater than 350 ug/L (32% of the patients); 10% and 20% of them had values below 4 ug/L and 10 ug/L respectively. It is concluded that the trend is the same as in the studies and there is the need for prostate gland volume studies and evaluation of women who have detectable PSA values.
在尼日利亚非洲人群中对前列腺特异性抗原的生物学特性进行了研究。选取了214人进行该研究。该组由59名明显健康的男性(年龄范围22 - 76岁)、58名经活检证实患有前列腺癌的男性(年龄范围40 - 91岁)、81名经活检证实患有良性前列腺增生(BPH)的男性(年龄范围46 - 87岁)以及16名女性(年龄范围23 - 47岁)组成。他们的中位年龄分别为53岁、66岁、66岁和27岁。对照组人群的中位PSA值为0.7微克/升(范围0.1 - 4.3微克/升),其中98.3%的人的PSA值低于4微克/升。50岁以下的人没有PSA值大于2微克/升的。在整个年龄范围内,年龄与血清PSA值之间存在显著相关性(r = 0.523;P = 0.001)。在女性研究组中,4人(25%)有可检测值,但其原因无法确定。BPH患者的中位PSA值为8.5微克/升(范围0.2 - 350微克/升)。在该组中,37%的人值低于4微克/升,54.3%的人值低于10微克/升。在患有前列腺癌的患者中,中位PSA值为92.6微克/升,众数大于350微克/升(32%的患者);他们分别有10%和20%的值低于4微克/升和10微克/升。结论是该趋势与研究中的相同,并且有必要对前列腺体积进行研究以及对有可检测PSA值的女性进行评估。